'My journey: A tryst with cancer prevention'
Date: Thursday 13 Apr 2023Time: 5.30-7.30pmLocation: G02 Lecture Theatre, Joseph Rotblat Building, CHSQRegistration: Eventbrite
Register
Clinical academia in a complex surgical speciality can be challenging. In this lecture I describe and reflect on my journey in gynaecological oncology research, my challenges, milestones, friendships, and collaborations. A large number of women’s cancers occur in women at increased risk and can be prevented. I will discuss my research programme in Targeted Precision Prevention, the road travelled and some plans going forward. My journey covers trials and research in population-based genetic testing, mainstreaming genetic testing, population risk stratification, targeted screening, targeted cancer prevention, related health economic issues and a commitment to teaching and training.
Speaker bio
Ranjit Manchanda is a Professor at Wolfson Institute of Population Health, Faculty of Medicine & Dentistry, Queen Mary University of London. He co-leads the Cancer Prevention Unit in the Centre for Prevention, Detection & Diagnosis. He is a Consultant Gynaecological Oncologist at Barts Health NHS Trust, London and leads their Women’s Precision Prevention Service. He is the Integrated Academic Training Programme Director, London Specialty School of Obstetrics & Gynaecology, Health Education England. He also holds an Honorary Professorship at the Department of Health Services Research, London School of Hygiene & Tropical Medicine and the Distinguished Infosys Chair in Oncology at All India Institute of Medical Sciences, Delhi, India.
He completed his PhD and NIHR Academic Clinical Lectureship at University College London along with subspecialty training in gynaecological oncology at UCLH & Barts Health. Ranjit’s main research interests are focused around Targeted Precision Prevention. This includes population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, targeted screening, targeted cancer prevention, along with health economic issues related to these areas of research.
Please note that this is an in person event only